ʻO Peptide Custom Synthesis 7-La Hoʻouna

Hāʻawi i nā ala noiʻi hiki ke kūpono no
ʻepekema peptide
Keena hoʻomaʻemaʻe maʻemaʻe
0 Papa
Nā kaʻina hana a hiki i 100AA
0 AA
Hui hoʻololi peptide 300+
0 +
E koho mai ka palau a i 99% ka maemae.
0 +

Nā lawelawe a me nā huahana

Hoʻopili ʻia ʻo Peptide Synthesis

· 99% maʻemaʻe
· Mai ka mg-kg
· Nā kaʻina hana maʻamau a hiki i 200AA

ʻO nā peptide hoʻonani

· Tripeptide-1;GHK-Cu
· Acetyl hexapeptide-8
· paʻi-8;AHK- Cu

Catalog Peptide

· Antigen Peptides
· Antimicrobial Peptides
· Peptide Kuʻi Kelepona

Hoʻololi

· Kaumaha ʻia ka isotope kaumaha
·C-terminal; N-terminal
.ʻO Glycopeptides;Cyclic Peptide

Lepili peptide

· Biotinylation
· Hoʻopaʻa ʻia ʻo Fluorescent
· Mea hōʻailona Antibody

Peptide CRO

· Hoʻolālā a me ka Synthesis
· Ka Hoʻomohala Hana
· Kākoʻo ʻenehana

peptide hoao

·MS;HPLC;PH
· Maʻemaʻe; Maʻiʻo
· Endotoxin

Pehea e hana maikaʻi ai

Papa 100 lumi hoʻomaʻemaʻe

Mai ka ʻanuʻu mua i ka hoʻomaka ʻana o ka hoʻokolohua a i ka pae hope o ka hoʻopili ʻana, mālama mau ʻia i loko o kahi ʻano ʻino a hoʻomaʻemaʻe ʻia.

ʻIke ʻakomi a hoʻoponopono: Ka hoʻopaʻa ʻana; kaomi ea; haʻahaʻa; mahana wela; hopu ʻia nā ʻāpana lepo a hoʻoponopono ʻia.

Pūʻulu ʻenehana Organic a me Biological Dual Domain

Hele mai kā mākou mau ʻenehana mai ka ʻoihana kemika a me ka biology, a ua akamai i nā ʻano hana peptide synthesis, me ka peptide synthesis paʻa, ka hoʻoheheʻe ʻana o ka peptide wai, hui pū ʻia ka wai-paʻa peptide synthesis, ka hoʻohui ʻana i ka peptide ʻano paʻa paʻa, a me ka fermentation microbial.

Ka hoomalu maikai: ʻO ka nānā ʻana iā ʻoe iho ma ke ʻano he kumu no ka hoʻolaha ʻana i ka hana.

ʻO ka lawe ʻana i ka ʻike mua ma ke ʻano he mea noʻonoʻo a noʻonoʻo ʻaʻole hiki ke hoʻoholo i kēlā me kēia kaʻina hana, ua lilo ia i code of conduct e hoʻomau i ka hoʻāʻo pinepine ʻana i kēlā me kēia kaʻina hana a e hoʻokele i ke kaʻina hana aʻe me ka ʻikepili maoli ma ke ʻano he hōʻike kākoʻo., ʻo ia hoʻi ka nānā ʻana i nā ʻāpana i loko o ke kaiapuni; haʻahaʻa; mahana wela; kaomi; a me ka maemae; maʻiʻo; endotoxin; Waiwai PH; sterility i ka hana, a pela aku.

Nā lako hana: peptide synthesis i ka lyophilization, mai mg a i kg

Mai ka mg o nā peptides maʻamau no ka noiʻi ʻepekema i kg o nā peptides cosmetic, Loaʻa iā mākou nā lako kikoʻī a pau mai ka synthesis; ka hoomaemae ana; hoomakaukau ana; lyophilization; hoao ana.

ʻIkepili Frontier

E hahai i kā mākou mau hana ʻenehana hou loa a me ka ʻike ʻokiʻoki i ke kahua peptide.

Why Faster Australian Phase 1 Timelines Are Pressuring CRO Operations

Why Faster Australian Phase 1 Timelines Are Pressuring

Why Australian Phase 1 Timelines Rewrote the Critical Path A Chemical & Engineering News analysis published in 2026 traced the surge of

Gel Filtration Resin Demand Doubling by 2035: Peptide Purification Strategy

Gel Filtration Resin Demand Doubling by 2035: Peptide

The Forecast: A Doubling of Demand, Not a Blip The headline number comes from market analysis that models the global preparative gel

Cyclic Peptide Phage-Display Validation Workflow: What the Cbl-b Study Shows

Cyclic Peptide Phage-Display Validation Workflow: What the Cbl-b

Why Cbl-b Is a Demanding Test Case Cbl-b (Casitas B-lineage lymphoma-b) is an E3 ubiquitin ligase that raises the activation threshold of

Hoʻokaʻaʻike a me ke kōkua

E nīnau mai iā mākou i kekahi mea ma ke kahua peptide.

E kelepona i kahi loea peptide

E kamaʻilio wikiwiki ma o whatsapp a i ʻole e hoʻouna i kāu mau pono a me nā nīnau ma o ka palapala.

FAQ

E nānā i kā mākou FAQ no ka loaʻa wikiwiki o ka ʻike.

Home Huli Whatsapp Nā lawelawe Huahana